Whitehawk Therapeutics (WHWK) Competitors $1.90 +0.03 (+1.60%) As of 04:00 PM Eastern Add Compare Share Share Competitors Stock AnalysisChartCompetitorsSEC FilingsTrendsBuy This Stock WHWK vs. ATNFW, LBPSW, AEHAW, AIMDW, ALVOW, ACABW, BFRIW, BTMDW, BCTXW, and CALAShould you be buying Whitehawk Therapeutics stock or one of its competitors? The main competitors of Whitehawk Therapeutics include 180 Life Sciences (ATNFW), 4D pharma (LBPSW), Aesther Healthcare Acquisition (AEHAW), Ainos (AIMDW), Alvotech (ALVOW), Atlantic Coastal Acquisition Corp. II (ACABW), Biofrontera (BFRIW), biote (BTMDW), BriaCell Therapeutics (BCTXW), and Calithera Biosciences (CALA). These companies are all part of the "pharmaceutical products" industry. Whitehawk Therapeutics vs. Its Competitors 180 Life Sciences 4D pharma Aesther Healthcare Acquisition Ainos Alvotech Atlantic Coastal Acquisition Corp. II Biofrontera biote BriaCell Therapeutics Calithera Biosciences 180 Life Sciences (NASDAQ:ATNFW) and Whitehawk Therapeutics (NASDAQ:WHWK) are both pharmaceutical products companies, but which is the better investment? We will compare the two businesses based on the strength of their institutional ownership, analyst recommendations, dividends, profitability, media sentiment, risk, earnings and valuation. Does the media prefer ATNFW or WHWK? In the previous week, 180 Life Sciences had 2 more articles in the media than Whitehawk Therapeutics. MarketBeat recorded 2 mentions for 180 Life Sciences and 0 mentions for Whitehawk Therapeutics. 180 Life Sciences' average media sentiment score of 1.41 beat Whitehawk Therapeutics' score of 0.00 indicating that 180 Life Sciences is being referred to more favorably in the media. Company Overall Sentiment 180 Life Sciences Positive Whitehawk Therapeutics Neutral Do institutionals & insiders hold more shares of ATNFW or WHWK? 52.1% of Whitehawk Therapeutics shares are owned by institutional investors. 49.9% of Whitehawk Therapeutics shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth. Is ATNFW or WHWK more profitable? Whitehawk Therapeutics has a net margin of 99.42% compared to 180 Life Sciences' net margin of 0.00%. 180 Life Sciences' return on equity of 0.00% beat Whitehawk Therapeutics' return on equity.Company Net Margins Return on Equity Return on Assets 180 Life SciencesN/A N/A N/A Whitehawk Therapeutics 99.42%-56.73%-48.68% Which has preferable earnings and valuation, ATNFW or WHWK? 180 Life Sciences has higher earnings, but lower revenue than Whitehawk Therapeutics. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio180 Life SciencesN/AN/AN/AN/AN/AWhitehawk Therapeutics$25.98M3.45-$63.69M$0.1611.88 Summary180 Life Sciences and Whitehawk Therapeutics tied by winning 4 of the 8 factors compared between the two stocks. Get Whitehawk Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for WHWK and its competitors with MarketBeat's FREE daily newsletter. Email Address Media Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart WHWK vs. The Competition Export to ExcelMetricWhitehawk TherapeuticsPharmaceutical Preparations IndustryManufacturing SectorNASDAQ ExchangeMarket Cap$89.51M$772.40M$2.23B$8.84BDividend YieldN/A4.84%2.63%4.21%P/E Ratio11.881.3123.3319.57Price / Sales3.45223.9157.8199.95Price / CashN/A23.44N/A56.49Price / Book0.906.121.935.50Net Income-$63.69M-$26.79M-$332.31M$248.67M7 Day PerformanceN/A-1.05%0.73%2.12%1 Month PerformanceN/A6.82%3.47%5.81%1 Year PerformanceN/A9.08%20.47%18.23% Whitehawk Therapeutics Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)WHWKWhitehawk TherapeuticsN/A$1.90+1.6%N/AN/A$89.51M$25.98M11.8840ATNFW180 Life SciencesN/A$0.01+1.2%N/A-14.3%$0.00N/A0.007LBPSW4D pharmaN/AN/AN/AN/A$0.00$522K0.00N/AAEHAWAesther Healthcare AcquisitionN/A$0.01flatN/AN/A$0.00N/A0.002AIMDWAinosN/A$0.13-21.0%N/A+89.1%$0.00$106.21K0.0040Gap DownALVOWAlvotechN/A$1.72-0.6%N/A-56.5%$0.00$585.60M0.004Gap DownACABWAtlantic Coastal Acquisition Corp. IIN/A$0.03+6.5%N/A-67.2%$0.00N/A0.0015Gap UpBFRIWBiofronteraN/A$0.09-1.1%N/A+122.2%$0.00$38.00M0.0070BTMDWbioteN/A$0.02+41.3%N/AN/A$0.00$199.38M0.00N/AGap DownBCTXWBriaCell TherapeuticsN/A$0.07-10.6%N/A-70.6%$0.00N/A0.008News CoverageGap DownCALACalithera Biosciences0.5593 of 5 stars$0.00flatN/A-99.2%$0.00N/A0.0060Gap Down Related Companies and Tools Related Companies ATNFW Competitors LBPSW Competitors AEHAW Competitors AIMDW Competitors ALVOW Competitors ACABW Competitors BFRIW Competitors BTMDW Competitors BCTXW Competitors CALA Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:WHWK) was last updated on 6/26/2025 by MarketBeat.com Staff From Our PartnersThe DOJ Just Paved the Way for Account SeizuresWashington is running out of money…And guess where they'll look next? When governments go broke, they take ...Priority Gold | Sponsored3..2..1.. AI 2.0 ignition (don’t sleep on this)I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | SponsoredThe Recession Already Started, Are You Prepared?Global central banks are stockpiling gold. Billionaires are hedging with precious metals. And thousands of Ame...Lear Capital | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredWe’ve Entered the Most Bullish Phase of the CycleIt happens like clockwork. Every four years, the crypto market enters a new phase — and for those who know how...Crypto Swap Profits | SponsoredTrump: "Buy Stocks Now!" (Here's a Better Move)Trump: "Buy Stocks Now!" (Here's a Better Move) President Trump just announced from the Oval Office: "You b...Investors Alley | SponsoredTrump set to Boost Social Security Checks by 400%?If you're currently collecting—or planning to collect—Social Security benefits, there's an urgent development ...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Whitehawk Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Whitehawk Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy WHWK Stock Free WHWK Stock Alerts